Philadelphia Trust Company’s CME Group CME Stock Holding History

Philadelphia Trust Company’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$430K	Sell	1,455 -200	-12%	-$59.4K	0.03%	171
2025 Q4	$452K	Hold	1,655	–	–	0.03%	167
2025 Q3	$447K	Sell	1,655 -45	-3%	-$12.2K	0.03%	165
2025 Q2	$469K	Buy	1,700 +100	+6%	+$27.2K	0.04%	156
2025 Q1	$424K	Buy	1,600 +145	+10%	+$35.8K	0.04%	166
2024 Q4	$338K	Sell	1,455 -14	-1%	-$3.22K	0.02%	191
2024 Q3	$324K	Buy	1,469 +14	+1%	+$2.9K	0.02%	196
2024 Q2	$286K	Hold	1,455	–	–	0.02%	186
2024 Q1	$313K	Hold	1,455	–	–	0.03%	184
2023 Q4	$306K	Buy	+1,455	New	+$310K	0.03%	181
2014 Q3	–	Sell	-5,000	Closed	-$355K	–	160
2014 Q2	$355K	Sell	5,000 -250	-5%	-$17.6K	0.02%	136
2014 Q1	$389K	Hold	5,250	–	–	0.02%	140
2013 Q4	$412K	Sell	5,250 -60	-1%	-$4.7K	0.03%	152
2013 Q3	$392K	Hold	5,310	–	–	0.03%	139
2013 Q2	$403K	Buy	+5,310	New	+$348K	0.03%	131

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Philadelphia Trust Company's CME Position: Q1 2026 in Review

Philadelphia Trust Company reduced its CME Group (CME) stake by 12% in Q1 2026, selling an estimated $59.4K and leaving 1,455 shares worth $430K. The position accounts for 0.03% of the portfolio, ranked #171.

Philadelphia Trust Company first reported a position in CME in Q2 2013 and has held it in 15 quarters since. The position peaked at $469K in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Philadelphia Trust Company held 1,455 shares of CME Group worth $430K as of Q1 2026.
Philadelphia Trust Company sold 200 CME Group shares in Q1 2026, an estimated $59.4K.
CME Group made up 0.03% of Philadelphia Trust Company's portfolio in Q1 2026, its #171 holding.
Philadelphia Trust Company first reported a position in CME Group in Q2 2013 and has held it in 15 quarters since.
Philadelphia Trust Company's CME Group position peaked at $469K in Q2 2025.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.